Understanding brain disorders caused by metabolic issues in children
Mechanisms of Disease and Treatment in Novel Metabolic Developmental Brain Disorders
This study is looking into a new genetic condition called GPT2 disease that affects how children's brains grow and move, and it aims to find helpful treatments like diet changes and supplements to support their brain health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brown University NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-10991030 on NIH RePORTER |
What this research studies
This research investigates a newly identified genetic disorder linked to a mitochondrial enzyme that affects brain development in children. It focuses on understanding how this disorder, known as GPT2 disease, leads to brain undergrowth and movement difficulties. The research aims to explore potential treatment strategies, including dietary changes and supplements, to support brain health and development. By conducting pre-clinical studies, the team hopes to establish effective interventions for affected children.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who have been diagnosed with GPT2 disease or related metabolic disorders.
Not a fit: Patients with brain disorders not related to metabolic issues or those outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that improve brain development and function in children with GPT2 disease.
How similar studies have performed: Other research has shown promise in treating metabolic brain disorders through dietary interventions, suggesting potential success for this approach.
Where this research is happening
Providence, United States
- Brown University — Providence, United States (Active)
Researchers
- Principal investigator: Morrow, Eric M — Brown University
- Study coordinator: Morrow, Eric M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.